Endpoint NewsMay 22, 2023
“As it awaits key readout, Hepion boosts confidence in NASH drug hopeful via shorter study”
EndpointsSeptember 12, 2022
Hepion Pharma Announces First Dosing in Phase 2b Clinical Trial with HepQuant
Press Releases
June 13, 2023
HepQuant Announces Additions to the Executive Leadership Team to Drive Commercialization
Kelly R. Pitts, PhD, Chief Operating Officer; Carrie Mulherin, MBA, Chief Commercial Officer; Shailesh Chavan, MD, Chief Medical Officer; Paige Nardi, MBA VP Market Access Denver, CO – June 13, 2023 – HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team….
April 14, 2023
Kelly R. Pitts, Ph.D., Appointed Chief Operating Officer
Medical Diagnostics Industry Veteran with Biotech and Biopharma Experience Will Guide Operations DENVER (Apr. 14, 2023) — HepQuant, LLC, a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced its has chosen Kelly R. Pitts, Ph.D., as its new Chief…